Our mission is to help you obtain financial freedom. Checkout Our Youtube Channel Checkout Our Youtube Channel
Blog

$NVAX Receives FDA Approval, Key Price Targets After 10%+ Intraday Rally

Novavax (NVAX) has been one of our best performing stocks that has been trading in an accumulation range between $7 and $9. I believe that NVAX is trending for an upward breakout in Q4. The FDA has approved NVAX’s COVID vaccine for patient ages 12+, and the European Union is set to make a decision in October. I believe that NVAX has promising short-term outlook that will lead to a rally with a break above $9. So far $9.18 has been a key resistance target, but I believe that NVAX will ultimately break out to the light blue resistance level at $16.21

TradingView chart:
https://www.tradingview.com/chart/NVAX/sG5ojvU3-NVAX-Key-Price-Targets-After-10-Intraday-Rally/

0 Comments
Inline Feedbacks
View all comments

More ClearValue Insights

Default Thumbnail

TLT

Anyone investing in the ETF

Read More

Money Dysmorphia: Causes and Treatment

Are you stressed about money? You may have money dysmorphia and not even know it. And this may cause you to make bad financial decisions. What is Money Dysmorphia? Money dysmorphia is when you have a distorted view of your finances. This phenomenon is similar to body dysmorphia, where individuals perceive flaws in their physical […]

Read More
Default Thumbnail

How Keep Your Money and Combat Inflation

Rising prices due to inflation can put a strain on your budget and savings. When the cost of goods and services increases, your money doesn’t stretch as far. This erosion of purchasing power makes it harder to maintain your standard of living. However, by understanding how inflation works and taking proactive steps, you can mitigate […]

Read More